Oral Iron in Pregnant Women: How Often to Take It and Its Side Effects and Tolerability

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-50
SponsorBnai Zion Medical Center

About this trial

The goal of this prospective observational study is to examine the frequency of gastrointestinal side effects associated with oral iron supplementation during pregnancy. The main question it aims to answer is:

Does intermittent oral iron supplementation result in fewer gastrointestinal side effects compared with daily supplementation in pregnant women? Pregnant women who are prescribed oral iron as part of their routine medical care will take ferrous sulfate on an alternate-day schedule for one week. If no significant gastrointestinal side effects are reported, they will then take ferrous sulfate daily for an additional week and will be followed for one month. Participants will be contacted by the study investigator to report gastrointestinal side effects, and routine blood tests will be used to assess changes in hemoglobin and iron stores.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Pregnant women aged 18-50

Indication for oral iron treatment as determined by the treating physician, in accordance with standard clinical practice

Baseline iron store levels measured prior to initiation of oral iron therapy

Disqualifiers

Women taking ferrous sulfate 80 mg Tardiferon

Gastrointestinal diseases such as colitis

Women who received intravenous iron during pregnancy

Women who received blood transfusions during pregnancy

Trial population

Pregnant women attending our high-risk pregnancy clinics (in Bnai Zion medical center)

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • No intervention. It's an observational study

    Other intervention

    No intervention. It's an observational study

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Incidence of gastrointestinal side effects in response to iron intake

Time frame
Over the first 2 weeks of supplementation, with structured follow-up at week 1 and week 2

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: